| abstract |
The present disclosure relates generally to the methods of treatment of mammalian subjects byan enhanced cell-based therapeutic approach in order to facilitate tissue and neuronal repair, regeneration and/or reparation. Medicaments useful in the treatment of mammalian subjects and methods of production of the medicaments are also encompassed by the present disclosure, wherein the composition comprises exosomes derived from allogenic mammalian amnion epithelial cells from a donor mammal of the same species. |